About 3-hydroxy-3-methylglutaric aciduria
3-hydroxy-3-methylglutaric aciduria is a rare disease catalogued by Orphanet (ORPHA:20). It is associated with the HMGCL gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to 3-hydroxy-3-methylglutaric aciduria trials.
Search ClinicalTrials.gov for "3-hydroxy-3-methylglutaric aciduria" or filter by Orphanet code ORPHA:20 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting 3-hydroxy-3-methylglutaric aciduria trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for 3-hydroxy-3-methylglutaric aciduria. Updated daily.